Cheryl Cullen

Title: Cheryl Cullen - Innovator in Glaucoma Treatment

Introduction

Cheryl Cullen is a notable inventor based in Stratford, CA, recognized for her contributions to medical technology. She has developed an innovative device aimed at treating primary glaucoma in both humans and animals, particularly dogs. Her work exemplifies the intersection of veterinary and human medicine, showcasing her commitment to improving the quality of life for those affected by this condition.

Latest Patents

Cullen holds a patent for the "Sinus Valved Glaucoma Shunt." This invention relates to a device and method for treating primary glaucoma by draining or diverting aqueous humor extraocularly. The shunt implant is designed to ensure fluid flow from the eye directly into the frontal sinus cavity via tubing. The device features crossbeam aids for anchoring, four slit valves to control fluid flow, and a bulb that secures the device in the frontal sinus cavity. Made from medical-grade radiopaque silicone rubber, the shunt is flexible and designed for ease of implantation.

Career Highlights

Cheryl Cullen has made significant strides in her career, particularly through her work at Eagle Vision, Inc. Her innovative approach to medical devices has garnered attention in the field of ophthalmology. With a focus on improving treatment options for glaucoma, her contributions are paving the way for advancements in both human and veterinary medicine.

Collaborations

Cullen collaborates with Lewis H Marten, enhancing her research and development efforts. Their partnership exemplifies the importance of teamwork in the innovation process, particularly in the medical field.

Conclusion

Cheryl Cullen's work in developing the Sinus Valved Glaucoma Shunt highlights her dedication to advancing medical technology for glaucoma treatment. Her innovative spirit and collaboration with colleagues like Lewis H Marten continue to inspire progress in this vital area of healthcare.